Matthew G. Oser, MD, PhD

Dr. Oser is a Physician-Scientist in the Department of Medical Oncology at Dana-Farber Cancer Institute and an Assistant Professor of Medicine at Harvard Medical School. He is also an Associate Member at the Broad Institute and an Attending Medical Oncologist in the Lowe Center for Thoracic Oncology at Dana-Farber Cancer Institute. He received his BA in Biology from Oberlin College. He subsequently received his MD and PhD from Albert Einstein College of Medicine, where he did his graduate work in the lab of Dr. John Condeelis studying mechanisms of tumor cell invasion in breast cancer. He then completed residency training in Internal Medicine at the Brigham and Women's Hospital and a fellowship in Medical Oncology at the Dana-Farber/Harvard Cancer Center Program where he became interested in thoracic oncology. He completed his postdoctoral fellowship in Dr. William G. Kaelin Jr.'s laboratory at Dana-Farber Cancer Institute where he used CRISPR/Cas9 screening to identify new targeted therapy approaches for small cell lung cancer (SCLC) and also used CRISPR/Cas9 to develop a new genetically engineered mouse model of small cell lung cancer. In 2019, he began leading a research laboratory at Dana-Farber focused on understanding SCLC pathogenesis with the goal to bring better therapies to our patients with SCLC. He is originally from Columbus, Ohio.